Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | HTR2B | P41595 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7773567 | 0.92 | KMT2A (0.50) | KMT2AMEN1NR1I2LMNACHRM2 | |
| SCHEMBL1320478 | 0.85 | L3MBTL1 (0.50) | KMT2AMEN1LMNAKDM4EALDH1A1 | |
| SCHEMBL26696240 | 0.85 | MAPT (0.51) | KMT2AMEN1NR1I2LMNACHRM2 | |
| SCHEMBL3936646 | 0.84 | ALDH1A1 (0.53) | KMT2AMEN1LMNACYP2C9KDM4E | |
| SCHEMBL301123 | 0.83 | KMT2A (0.69) | KMT2AMEN1NR1I2LMNACHRM2 | |
| SCHEMBL29994009 | 0.83 | KMT2A (0.69) | KMT2AMEN1NR1I2LMNACHRM2 | |
| Benzene SCHEMBL28006345 | 0.83 | KMT2A (0.69) | KMT2AMEN1NR1I2LMNACHRM2 | |
| SCHEMBL7921354 | 0.83 | CYP1A2 (0.70) | KMT2AMEN1NR1I2LMNACHRM2 | |
| SCHEMBL9774307 | 0.83 | KMT2A (0.51) | KMT2AMEN1NR1I2LMNACHRM2 | |
| SCHEMBL4960309 | 0.83 | KMT2A (0.51) | KMT2AMEN1NR1I2LMNACHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11998603-B2 | Fluorescein and benoxinate compositions | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-06-04 | — | — | US | disclosed |
| US-20230263894-A1 | FLUORESCEIN AND BENOXINATE COMPOSITIONS | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2023-08-24 | — | — | US | disclosed |
| WO-2023149406-A1 | CURABLE RESIN COMPOSITION, RESIN CURED FILM, PARTITION WALL AND OPTICAL ELEMENT | ＡＧＣ株式会社 | 2023-08-10 | — | — | WO | disclosed |
| US-11452779-B2 | Fluorescein and benoxinate compositions | Paragon BioTeck, Inc. (US) | 2022-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11452779-B2 | Fluorescein and benoxinate compositions | BTD, DHFR, BLVRB | KMT2A 3908/4885MEN1 2992/4885NR1I2 3258/4885 |
| US-20230263894-A1 | FLUORESCEIN AND BENOXINATE COMPOSITIONS | BTD, DHFR, BLVRB | KMT2A 3908/4885MEN1 2992/4885NR1I2 3258/4885 |
| US-11998603-B2 | Fluorescein and benoxinate compositions | BTD, DHFR, BLVRB | KMT2A 3908/4885MEN1 2992/4885NR1I2 3258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.